Skip links

Vpriv® (velaglucerase alfa)

Full Name Vpriv® (velaglucerase alfa)
Drug Vpriv
Manufacturer Takeda Pharmaceuticals U.S.A., Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Long-term enzyme replacement therapy (ERT) for pediatric and adult patients with type 1 Gaucher disease
Disease Gaucher Type I Disease
Therapeutic Area Neurology, Genetics
Enrollment Form Link Vpriv Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website